ARI VENOMUNA BAĞLI ANAFİLAKSİ: KLİNİK DENEYİMİMİZ

Abstract

Amaç Arı alerjileri en sık anafilaksi nedenlerindendir ve şiddetli anafilaksi ile karakterizedir. Amacımız arı venomuna bağlı anafilaksi geçiren erişkin olgularda reaksiyona yol açan arı türleri ile gelişen anafilaksinin şiddeti, in-vivo ve in-vitro test sonuçları ile olguların demografik özelliklerini araştırmaktır. Gereç ve Yöntem Mart 2017- Haziran 2022 tarihleri arasında kliniğimizde arı alerjisine bağlı sistemik reaksiyon nedeniyle takipli ve Amerikan Ulusal Alerji ve Enfeksiyon Hastalıkları Enstitüsü (National Institutes of Allergy and Infectious Disease, NIAID) ile Besin Alerjileri ve Anafilaksi Ağı (Food Allergy and Anaphylaxis Network, FAAN) tarafından 2006 yılında geliştirilen ölçütlere göre anafilaksi kriterlerine uyan olgular alındı. Arı türü, bazal triptaz, Total IgE ve venom spesifik IgE düzeyleri, deri testi sonuçları kaydedildi. Anafilaksi şiddeti Mueller kriterlerine göre skorlandı. Ataklarda adrenalin kullanımı, adrenalin otoenjektörü bulundurma değerlendirildi. Bulgular Toplam 102 arı ilişkili anafilaksi olgusundan %53,9’unun erkek olup ortalama yaşın 44.8 olduğu saptandı. Arı türü açısından %69,6 olguda bal arısı (Apidae), %19,6 olguda yaban arısı (Vespidae), %10,8 olguda ise her iki türle anafilaksi geliştiği belirlendi. Anafilaksi şiddeti Mueller sınıflanmasına göre %10,7 olgu Grade I, %58,8 Grade II, %27,45 Grade III, %2,91 ise Grade IV ile uyumluydu. Atak sıklığı açısından 20 olgu tek atak, 37 olgu 2, 42 olgu ise 3 veya daha fazla anafilaksi atağı geçirdiği belirlendi. Hastaların %44,11’inde atopi saptandı. Yaş, cinsiyet, atopik durum, kronik hastalık birlikteliği, ek ilaç kullanımı ve kanda eosinofil, total IgE düzeyleri ile reaksiyon şiddeti arasında anlamlı bir ilişki saptanmadı. Hastaların %80,4’üne adrenalin otoenjektör reçetelenmesine rağmen tedavide adrenalin kullanım oranı %31,4 saptandı. Sonuç Arı venom ilişkili anafilakside olguların çoğu birden fazla atak geçirmesine rağmen tedavide adrenalin kullanım oranları düşük seviyelerde kalmaktadır. En sık anafilaksi bal arısı sokmasına bağlı olarak gelişirken erkek cinsiyette riskin daha fazla olduğu saptandı

Keywords

• Anafilaksi
• epinefrin
• risk faktörleri
• arı venom alerjisi

HYMENOPTERA VENOM-INDUCED ANAPHYLAXİS: OUR CLİNİCAL EXPERİENCE

Abstract

Objective Venom allergies are the most common cause of anaphylaxis in adults and are characterized by severe anaphylaxis. We aim to investigate the relationship rebetween the bee species causing the reaction and the severity of anaphylaxis, in-vivo and in-vitro test results and demographic characteristics of the cases in adult patients who were treated in the allergy clinic for bee venom-related anaphylaxis. Material and Method Patients who developed systemic reaction due to bee venom allergy in the adult allergy clinic between March 2017 and June 2022 meeting the National Institutes of Allergy and Infectious Disease (NIAID) and Food Allergy and Anaphylaxis Network (FAAN) anaphylaxis criteria were included in the study. Demographic and clinical data (tryptase, total IgE, bee venom specific IgE levels and skin test) of all cases were evaluated. Anaphylaxis severity was scored according to the Mueller criteria. Adrenaline use in attacks and carrying an adrenaline auto-injector were evaluated. Results Among 102 cases, 53.9% were men and mean age was 44.80 years. It was determined that anaphylaxis developed with honeybee in 69.60%, wasps in 19.6%, and both species in 10.8%. The severity of anaphylaxis, according to Mueller classification were as follows: 10.7% Grade-I, 58.8% Grade-II, 27.45% Grade-III and Grade-IV 2.91%. In terms of attack frequency, it was determined that 20 patients had a single attack; 37 patients had 2 and 42 patients had 3 or more anaphylaxis attacks. Atopy was detected in 44.11% of the patients. No significant correlation was found between age, gender, atopic status, chronic disease coexistence, additional drug use, eosinophil levels, TIgE levels and the severity of the reaction. Although 80.4% of the patients were prescribed an adrenaline autoinjector, the rate of its usage in the treatment of attacks was 31.4%. Conclusion Most of the patients suffering from bee venom-induced anaphylaxis had a history of more than one attack. The rates of adrenaline use in emergency treatment still remain at low levels. In our study, honeybees are the most responsible type of bee; the males appear to be at a greater risk as compared to females.

Keywords

• Anaphylaxis
• epinephrine
• risk factors
• bee venom allergy

References

1. 1. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001-1006. doi:10.7326/0003-4819-140- 12-200406150-00009
2. 2. Simons FE, Chad ZH, Gold M. Anaphylaxis in children: Real-time reporting from a national network. Allergy Clinical Immunology. 2004;1:242
3. 3. Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal Anaphylaxis: Mortality Rate and Risk Factors. J Allergy Clin Immunol Pract. 2017;5(5):1169-1178. doi: 10.1016/j.jaip.2017.06.031
4. 4. Grigoreas C, Galatas ID, Kiamouris C, Papaioannou D. Insect- venom allergy in Greek adults. Allergy. 1997;52(1):51-57. doi:10.1111/j.1398-9995.1997.tb02545.x
5. 5. Golden DBK, O'Hehir RE, Holgate ST, Sheikh A. Insect Allergy. In: Middleton's Allergy Essentials. Edinburgh: Elsevier; 2017. p. 377-393
6. 6. Bilò MB. Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment. Allergy. 2011;66 Suppl 95:35-37. doi: 10.1111/j.1398-9995.2011.02630.x
7. 7. Graham DM, McPherson H, Lieberman P. Skin Testing in the Evaluation of Hymenoptera Allergy and Drug Allergy. Immunology and Allergy Clinics of North America. 2001; 21:301-20.
8. 8. Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN. EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60(11):1339- 1349. doi:10.1111/j.1398-9995.2005.00963.x

9. 9. Antonicelli L, Bilò MB, Bonifazi F. Epidemiology of Hymenoptera allergy. Curr Opin Allergy Clin Immunol. 2002;2(4):341-346. doi:10.1097/00130832-200208000-00008
10. 10. Kalyoncu AF. The prevalence of Hymenoptera stings in primary school children in Ankara. Int Rev Allergol Clin Immunol. 1998;4:136-144
11. 11. Müller UR. Hymenoptera venom hypersensitivity: an update. Clin Exp Allergy. 1998;28(1):4-6. doi:10.1046/j.1365- 2222.1998.00177.x
12. 12. Bilò BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol. 2008;8(4):330-337. doi:10.1097/ACI.0b013e32830638c5
13. 13. Jakob T, Rafei-Shamsabadi D, Spillner E, Müller S. Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics. Allergo J Int. 2017;26(3):93-105. doi:10.1007/s40629-017-0014-2
14. 14. Muraro A, Werfel T, Hoffmann-Sommergruber K, G Roberts, K Beyer, C Bindslev-Jensen et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-1025. doi:10.1111/all.12429
15. 15. Stoevesandt J, Hain J, Kerstan A, Trautmann A. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema. J Allergy Clin Immunol. 2012;130(3):698- 704.e1. doi:10.1016/j.jaci.2012.03.024
16. 16. Ruëff F, Przybilla B, Biló MB, Müller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124(5):1047- 1054. doi:10.1016/j.jaci.2009.08.027
17. 17. Golden DB, Breisch NL, Hamilton RG, Guralnick MW, Greene A, Craig T J, et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol. 2006;117(3):670-675. doi:10.1016/j.jaci.2005.12.1313
18. 18. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123:680-686
19. 19. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson Jr NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397. doi:10.1016/j.jaci.2005.12.1303
20. 20. Mueller Hl. Further experiences with severe allergic reactions to insect stings. N Engl J Med. 1959;261:374-377. doi:10.1056/ NEJM195908202610803
21. 21. Park KH, Lee J, Sim DW, Lee SC. Comparison of Singleplex Specific IgE Detection Immunoassays: ImmunoCAP Phadia 250 and Immulite 2000 3gAllergy. Ann Lab Med. 2018;38(1):23- 31. doi:10.3343/alm.2018.38.1.23
22. 22. Lockey RF, Turkeltaub PC, Baird-Warren IA, Olive CA, Olive ES, Peppe BC, et al. The Hymenoptera venom study I, 1979-1982: demographics and history-sting data. J Allergy Clin Immunol. 1988;82(3 Pt 1):370-381. doi:10.1016/0091-6749(88)90008-5
23. 23. Clark S, Long AA, Gaeta TJ, Camargo CA Jr. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol. 2005;116(3):643-649. doi:10.1016/j. jaci.2005.06.026
24. 24. Gelincik A, İşsever H, Unal D, Isik E, Demirturk M, Gul H, et al. The prevalence of Hymenoptera venom allergy in adults: the results of a very crowded city in Euroasia. Allergol Int. 2015;64(1):35-40. doi:10.1016/j.alit.2014.10.001
25. 25. Şimşek M, Seyfikli Z, Akkurt İ, Abadoğlu Ö, et al. Prevalance of venom allergy in Zara district at Sivas. T Klin Allerji Astım. 2000;2:127-132
26. 26. Worm M, Moneret-Vautrin A, Scherer K, Lang R, Fernandez‐Rivas M, Cardona V, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397- 1404. doi:10.1111/all.12475
27. 27. Bousquet J, Ménardo JL, Aznar R, Robinet-Lévy M, Michel FB. Clinical and immunologic survey in beekeepers in relation to their sensitization. J Allergy Clin Immunol. 1984;73(3):332-340. doi:10.1016/0091-6749(84)90405-6
28. 28. Karakaya G, Celebioglu E, Demir AU, Kalyoncu AF. The analysis of Hymenoptera hypersensitive patients in Ankara, Turkey. Allergol Immunopathol. 2012;40(1):9-13. doi:10.1016/j. aller.2010.11.002
29. 29. Kalyoncu AF, Demir AU, Ozcan U, Ozkuyumcu C, Sahin AA, Bariş YI. Bee and wasp venom allergy in Turkey. Ann Allergy Asthma Immunol. 1997;78(4):408-412. doi:10.1016/S1081- 1206(10)63203-6
30. 30. Annila IT, Karjalainen ES, Annila PA, Kuusisto PA. Bee and wasp sting reactions in current beekeepers. Ann Allergy Asthma Immunol. 1996;77(5):423-427. doi:10.1016/S1081-1206(10)63342-X
31. 31. Fernandez J, Blanca M, Soriano V, Sanchez J, Juarez C. Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area. Clin Exp Allergy. 1999;29(8):1069-1074. doi:10.1046/j.1365-2222.1999.00614.x
32. 32. Navarro LA, Peláez A, de la Torre F, Tenias Burillo JM, Megías J, Martínez I. Epidemiological factors on hymenoptera venom allergy in a Spanish adult population. J Investig Allergol Clin Immunol. 2004;14(2):134-141.
33. 33. Pérez Pimiento AJ, Prieto Lastra L, Rodríguez Cabreros MI, Vásquez Bautista AA, García Cubero A, Calvo Manuel E. Systemic reactions to wasp sting: is the clinical pattern related to age, sex and atopy? Allergol Immunopathol. 2007;35(1):10-14. doi:10.1157/13099089
34. 34. Przybilla B, Ring J, Grieshammer B. Association of features of atopy and diagnostic parameters in hymenoptera venom allergy. Allergy. 1991;46(8):570-576. doi:10.1111/j.1398-9995.1991. tb00625.x
35. 35. Sturm GJ, Heinemann A, Schuster C, et al. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Allergy. 2007;62(8):884-889. doi:10.1111/j.1398- 9995.2007.01413.x
36. 36. Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123(2):434- 442. doi:10.1016/j.jaci.2008.10.049
37. 37. Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J, et al. Anaphylaxis--a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341- 384. doi:10.1016/j.anai.2015.07.019
38. 38. Ramírez E, Cabañas R, Laserna LS, Fiandor A, Tong H, Prior N, et al. Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study. Clin Exp Allergy. 2013;43(3):344-352. doi:10.1111/cea.12034
39. 39. Yavuz ST, Sackesen C, Sahiner UM, Buyuktiryaki B, Arik Yilmaz E, Sekerel BE, et al. Importance of serum basal tryptase levels in children with insect venom allergy. Allergy. 2013;68(3):386- 391. doi:10.1111/all.12098
40. 40. Sahiner UM, Yavuz ST, Buyuktiryaki B, Cavkaytar O, Yilmaz EA, Tuncer A, et al. Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy. Allergy. 2014;69(2):265-268. doi:10.1111/all.1231.